文献詳細
増大特集 末梢神経・筋肉の自己免疫性・炎症性疾患ハンドブック
第2章 疾患各論
文献概要
自己免疫性自律神経節障害(autoimmune autonomic ganglionopathy:AAG)と急性自律性感覚性ニューロパチー(acute autonomic and sensory neuropathy:AASN)は免疫機序を基盤に発症する自律神経節あるいは後根神経節の障害を病態とする疾患である。AAG患者血清からはニコチン性自律神経節アセチルコリン受容体(ganglionic acetylcholine receptor:gAChR)に対する自己抗体が検出され,AAGの病原性自己抗体とされている。gAChR抗体はAASN患者血清では認めないとされる。AAGとAASNは現段階では臨床症状や各検査の所見からスペクトラム概念ではないと考えられる。しかし,自律神経外症状である脳症状(精神症状,性格変化を含む),内分泌障害は両者に共通して見られなんらかの病態基盤が共通する可能性を残している。
参考文献
1)Vernino S, Hopkins S, Wang Z: Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci 146: 3-7, 2009
2)Nakane S, Mukaino A, Higuchi O, Yasuhiro M, Takamatsu K, et al: A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy. J Autoimmun 108: 102403, 2020[doi: 10.1016/j.jaut.2020.102403]
3)中根俊成: 自己免疫性自律神経節障害. 鈴木則宏, 荒木信夫, 宇川義一, 桑原 聡, 塩川芳昭(編): Annual Review神経2020. 中外医学社, 東京, 2020, pp322-332
4)Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, et al: Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol 6: 988-992, 2008
5)Meeusen JW, Haselkorn KE, Fryer JP, Kryzer TJ, Gibbons SJ, et al: Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: active immunization model in mice. Neurogastroenterol Motil 25: 84-e10, 2013[doi: 10.1111/nmo.12030]
6)Flanagan EP, Saito YA, Lennon VA, McKeon A, Fealey RD, et al: Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil 26: 1285-1297, 2014
7)Okada F: Psychiatric aspects of acute pandysautonomia. Eur Arch Psychiatry Clin Neurosci 240: 134-135, 1990
8)Hayashi M, Ishii Y: A Japanese case of autoimmune autonomic ganglionopathy (AAG) and a review of AAG cases in Japan. Auton Neurosci 146: 26-28, 2009
9)Mukaino A, Nakane S, Higuchi O, Nakamura H, Miyagi T, et al: Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Mod Rheumatol 26: 708-715, 2016
10)Maeda Y, Nakane S, Higuchi O, Nakamura H, Komori A, et al: Ganglionic acetylcholine receptor autoantibodies in patients with autoimmune diseases including primary biliary cirrhosis. Mod Rheumatol 27: 664-668, 2017
11)McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ: Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol 66: 735-741, 2009
12)Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W: COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc 87: 1196-1201, 2012
13)Goldstein DS, Holmes C, Imrich R: Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: preliminary observations. Auton Neurosci 146: 18-21, 2009
14)Manganelli F, Dubbioso R, Nolano M, Iodice R, Pisciotta C, et al: Autoimmune autonomic ganglionopathy: a possible postganglionic neuropathy. Arch Neurol 68: 504-507, 2011
15)Morimoto N, Takahashi S, Inaba T, Takamiya M, Kageyama Y, et al: A case of seropositive autoimmune autonomic ganglionopathy with diffuse esophageal spasm. J Clin Neurosci 39: 90-92, 2017
16)Iodice V, Kimpinski K, Vernino S, Sandroni P, Low PA: Immunotherapy for autoimmune autonomic ganglionopathy. Auton Neurosci 146: 22-25, 2009
17)Schroeder C, Vernino S, Birkenfeld AL, Tank J, Heusser K, et al: Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353: 1585-1590, 2005
18)Winston N, Vernino S: Recent advances in autoimmune autonomic ganglionopathy. Curr Opin Neurol 23: 514-518, 2010
19)Hayashi T, Nakane S, Mukaino A, Higuchi O, Yamakawa M, et al: Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan. Ther Adv Neurol Disord 15: 17562864221110048, 2022[doi: 10.1177/17562864221110048]
20)Gupta A, Harris S, Vernino S, Naina HV: Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy. Clin Auton Res 25: 255-258, 2015
21)Bouxin M, Schvartz B, Mestrallet S, Debrumetz A, Hentzien M, et al: Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: case-report and literature review. J Neuroimmunol 326: 28-32, 2019
22)Iodice V, Kimpinski K, Vernino S, Sandroni P, Fealey RD, et al: Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology 72: 2002-2008, 2009
23)中根俊成: 自己免疫性自律神経ニューロパチー. 神田 隆(編): 末梢神経障害. 医学書院, 東京, 2022, pp270-277
24)Vernino S, Sandroni P, Singer W, Low PA: Invited article: autonomic ganglia: target and novel therapeutic tool. Neurology 70: 1926-1932, 2008
25)Koike H, Atsuta N, Adachi H, Iijima M, Katsuno M, et al: Clinicopathological features of acute autonomic and sensory neuropathy. Brain 133: 2881-2896, 2010
26)Colan RV, Snead OC 3rd, Oh SJ, Kashlan MB: Acute autonomic and sensory neuropathy. Ann Neurol 8: 441-444, 1980
27)Fagius J, Westerberg CE, Olsson Y: Acute pandysautonomia and severe sensory deficit with poor recovery: a clinical, neurophysiological and pathological case study. J Neurol Neurosurg Psychiatry 46: 725-733, 1983
28)長谷川康博: 急性自律性感覚性ニューロパチーの自律神経症候. 神経内科71: 555-560, 2009
29)向井栄一郎, 足立弘明: 急性自律性感覚性ニューロパチーの感覚症候. 神経内科71: 561-566, 2009
30)春木明代, 尾本雅俊, 神田 隆: 急性自律性感覚性ニューロパチーの神経病理. 神経内科71: 550-554, 2009
31)Tohgi H, Sano M, Sasaki K, Suzuki H, Sato T, et al: Acute autonomic and sensory neuropathy: report of an autopsy case. Acta Neuropathol 77: 659-663, 1989
32)Yasuda T, Sobue G, Hirose Y, Mimura M, Yanagi T: MR of acute autonomic and sensory neuropathy. AJNR Am J Neuroradiol 15: 114-115, 1994
33)Koike H, Watanabe H, Sobue G: The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. J Neurol Neurosurg Psychiatry 84: 98-106, 2013
34)桑原 聡: 急性自律性感覚性ニューロパチーの概念と疾患分類的位置づけ. 神経内科71: 547-549, 2009
35)Benarroch EE: The clinical approach to autonomic failure in neurological disorders. Nat Rev Neurol 10: 396-407, 2014
36)仙波純一: 双極スペクトラム概念の問題点を考える. 精神誌113: 1200-1208, 2011
37)小池春樹, 祖父江 元: Autoimmune autonomic ganglionopathyとacute autonomic and sensory neuropathy. 臨床神経53: 1326-1329, 2013
38)Goldstein DS: The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res 30: 299-315, 2020
39)Goldstein DS: Stress and the “extended” autonomic system. Auton Neurosci 236: 102889, 2021[doi: 10.1016/j.autneu.2021.102889]
40)山元敏正: 中枢自律神経線維網の形態と機能に関する最近の知見. Brain Nerve 74: 215-221, 2022
掲載誌情報